Handa Pharmaceuticals, Inc. (6620.TWO)

TWD 74.3

(-0.93%)

EBITDA Summary of Handa Pharmaceuticals, Inc.

  • Handa Pharmaceuticals, Inc.'s latest annual EBITDA in 2023 was 802.78 Million TWD , up 3007.95% from previous year.
  • Handa Pharmaceuticals, Inc.'s latest quarterly EBITDA in 2024 Q2 was 112.08 Million TWD , down -34.21% from previous quarter.
  • Handa Pharmaceuticals, Inc. reported an annual EBITDA of -27.68 Million TWD in 2022, up 87.72% from previous year.
  • Handa Pharmaceuticals, Inc. reported an annual EBITDA of -225.4 Million TWD in 2021, up 13.14% from previous year.
  • Handa Pharmaceuticals, Inc. reported a quarterly EBITDA of 169.14 Million TWD for 2024 Q1, down -2.2% from previous quarter.
  • Handa Pharmaceuticals, Inc. reported a quarterly EBITDA of 245.29 Million TWD for 2023 Q1, up 289.3% from previous quarter.

Annual EBITDA Chart of Handa Pharmaceuticals, Inc. (2023 - 2019)

Historical Annual EBITDA of Handa Pharmaceuticals, Inc. (2023 - 2019)

Year EBITDA EBITDA Growth
2023 802.78 Million TWD 3007.95%
2022 -27.68 Million TWD 87.72%
2021 -225.4 Million TWD 13.14%
2020 -264 Million TWD -40.51%
2019 -184.68 Million TWD 0.0%

Peer EBITDA Comparison of Handa Pharmaceuticals, Inc.

Name EBITDA EBITDA Difference
Allied Biotech Corporation 204.79 Million TWD -292.0%
GeneFerm Biotechnology Co., Ltd. 231.09 Million TWD -247.384%
Easywell Biomedicals, Inc. -85.5 Million TWD 1038.918%
TTY Biopharm Company Limited 1.52 Billion TWD 47.337%
Synmosa Biopharma Corporation 1 Billion TWD 20.417%
Orient EuroPharma Co., Ltd. 582.93 Million TWD -37.714%
Center Laboratories, Inc. -175.17 Million TWD 558.289%
Tien Liang BioTech Co., Ltd. 31.04 Million TWD -2485.622%
Orient Pharma Co., Ltd. 172.39 Million TWD -365.665%
InnoPharmax Inc. -62.12 Million TWD 1392.312%
Johnson Chemical Pharmaceutical Works Co., Ltd. 126.67 Million TWD -533.72%
Excelsior Biopharma Inc. -29.36 Million TWD 2833.44%
DV Biomed Co., Ltd. 407.64 Million TWD -96.935%
Foresee Pharmaceuticals Co., Ltd. -912.16 Million TWD 188.009%
UniPharma Co., Ltd. -16.25 Million TWD 5038.993%
Anxo Pharmaceutical Co., Ltd. 131.31 Million TWD -511.365%
Alar Pharmaceuticals Inc. 394.52 Million TWD -103.484%
Winston Medical Supply Co., Ltd. 228.32 Million TWD -251.597%
Mercury Biopharmaceutical Corporation -39.03 Million TWD 2156.628%
Bioray Biotech Co., Ltd 12.13 Million TWD -6515.443%
TSH Biopharm Corporation Limited 99.35 Million TWD -708.036%